Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Handling Sterile Components during Manufacturing – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Handling Sterile Components during Manufacturing – V 2.0

Standard Operating Procedure for Handling Sterile Components during Manufacturing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/029/2025
Supersedes SOP/SIM/029/2022
Page No. Page 1 of 15
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

This SOP establishes a standard method for handling sterile components during manufacturing to ensure integrity, sterility, and compliance with GMP and aseptic processing standards.

2. Scope

This SOP applies to all operations involving

the handling of sterilized items such as rubber stoppers, seals, sterile filters, vials, ampoules, and syringes used during aseptic filling in the Sterile Injectable Manufacturing area.

3. Responsibilities

  • Production Operator: Transfers, loads, and handles sterile components as per procedure.
  • Production Supervisor: Ensures compliance and documents all activities in BMR.
  • QA Officer: Verifies sterility assurance practices and performs line clearance.
  • Warehouse Personnel: Ensures delivery of sterilized components as per plan.
See also  Sterile Injectable Manufacturing: SOP for Calibration of Temperature Control Systems in Filling Machines - V 2.0

4. Accountability

The Head – Production and Head – Quality Assurance are accountable for maintaining the sterility of all components used in manufacturing.

5. Procedure

5.1 Pre-Checks

  1. Verify cleaning and sterilization status of components based on Sterilization Load Report.
  2. Ensure availability of approved BMR and materials issuance voucher.
  3. Check integrity of sterile bags and labels on each pack before aseptic transfer.

5.2 Transfer to Aseptic Area

  1. Transfer sterile components from the sterilizer using validated pass-through mechanisms (e.g., double-door autoclaves, dry heat depyrogenators).
  2. Use designated trolleys, fully sanitized and dedicated for aseptic processing.
  3. Perform QA line clearance before opening outer sterile bag.

5.3 Handling under Laminar Air Flow

  1. Open sterile bags inside the LAF under Grade A conditions.
  2. Inspect each component visually for any particulate or discoloration.
  3. Transfer items directly to filling machines or load into sterile bins/trays as per batch requirements.
See also  Sterile Injectable Manufacturing: SOP for Monitoring Room Conditions during Packaging - V 2.0

5.4 Component Usage and Controls

  1. Use components on FIFO basis, ensuring within approved shelf-life of sterilization.
  2. Document usage against the batch number in Annexure-1: Sterile Component Usage Log.
  3. Ensure batch-specific reconciliation at the end of use.

5.5 Post-Use Disposal

  1. Segregate unused components and return them to quarantine if applicable or discard as per SOP/SIM/075/2025 (Waste Disposal).
  2. Deface labels of discarded materials and document disposal details in Annexure-2.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • BMR: Batch Manufacturing Record
  • LAF: Laminar Air Flow
  • QA: Quality Assurance
  • FIFO: First In First Out

7. Documents

  1. Sterile Component Usage Log – Annexure-1
  2. Component Disposal Record – Annexure-2
  3. Line Clearance Checklist – Annexure-3

8. References

  • WHO TRS 961 Annex 6 – GMP for Sterile Pharmaceutical Products
  • ICH Q9 – Quality Risk Management
  • EU GMP Annex 1 – Manufacture of Sterile Medicinal Products
See also  Sterile Injectable Manufacturing: SOP for pH Testing of Injectable Products - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Sterile Component Usage Log

Date Component Qty Issued Qty Used Batch No. Operator
18/06/2025 Rubber Stopper 30,000 29,980 IV/275/25 Ajay Sharma

Annexure-2: Component Disposal Record

Date Component Qty Discarded Reason Disposed By Verified By
18/06/2025 Flip-off Seal 20 Damaged seal Sunil Reddy QA Officer

Annexure-3: Line Clearance Checklist

Parameter Status Remarks Checked By
Sterile Pack Integrity OK Sealed Priya Desai
Label Verification OK Correct batch Priya Desai

Revision History

Revision Date Revision No. Details Reason Approved By
01/02/2022 1.0 Initial SOP released New Document QA Head
18/06/2025 2.0 Inclusion of disposal log and updated QA role Periodic Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Biosimilars: SOP for Sterile Addition of Feeds and Supplements in Bioreactor Operations – V 2.0
Next Post: Analytical Method Development: LC-MS Method Development – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version